GlaxoSmithKline (GSK) Tops Q4 EPS by 4p

GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of GBP0.31, GBP0.04 better than the analyst estimate of GBP0.27. Revenue for the quarter came in at GBP8.2 billion versus the consensus estimate of GBP7.98 billion.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Burry doubles down on Nebius short after stock surges 34% on earnings